Episode 77: Endocrine Practice Endocrine Legends Series: Dr. Guillermo E. Umpierrez

Episode 77: Endocrine Practice Endocrine Legends Series: Dr. Guillermo E. Umpierrez

Join endocrine expert and Endocrine Practice Associate Editor, Dr. Cecilia M. Lansang, as she interviews Dr. Guillermo E. Umpierrez, professor of medicine at Emory University School of Medicine, clinician educator and researcher, for a candid conversation about his journey in medicine, endocrinology, and inpatient diabetes care. Dr. Umpierrez reflects on his early work studying diabetic ketoacidosis and ketosis-prone diabetes, the mentors and teams who shaped his academic career, and the importance of finding the right environment, enjoying the work and celebrating small successes along the way. To learn more, read Dr. Umpierrez’s review article in Endocrine Practice: Ketosis-Prone Type 2 Diabetes Mellitus: 3 Decades of Clinical, Pathophysiologic, and Therapeutic Insights [https://doi.org/10.1016/j.eprac.2026.03.007].

Episode 76: Endocrine Practice Endocrine Legends Series: Dr. David M. Nathan

Join endocrine expert and Endocrine Practice Associate Editor, Dr. Melissa Putman as she interviews renowned endocrinologist and diabetes researcher Dr. David Nathan for a candid and inspiring conversation reflecting on more than five decades of groundbreaking work in diabetes research and patient care. Together, they discuss Dr. Nathan’s remarkable career, including his work on the DCCT, diabetes prevention, and early GLP studies, while also exploring the future of diabetes research and advice for the next generation of researchers. To learn more, read Dr. Nathan’s review article in Endocrine Practice: Goodbye to All That? Personal Reflections on 50 years of Diabetes Research: Right Time, Right Place, Great Colleagues and Unwavering NIH Support [https://secure-web.cisco.com/1JzUhWN0pMeMFq0Wva0kR4PG-yZc6lNRcyaIrU13367GoHlVarujny49LHYUAuitNbtTpIjAcbo1o20P-rZh_1ZrN1y6mlWIXq0HRdkb_BBdrEPbqNuq8ndqrcykY-iGS6HB5ICUa_EM6w_ZF2YmsDiZONWeKgCqaAgUPrK-o5gcwCaGhnt4wvWtadpXWgHo7nu8ws4eK5dS2N_mExWTKbkA7dxl26e_3gmur5ESAEI4ceB5Lem7YrIJKYB4oS6a365o8KKaKjyWGjOhGVOl0vUz8baMqpUVgIypFXI1tiX2gLRYvwJsHoD_5dedxHKF9/https%3A%2F%2Fwww.endocrinepractice.org%2Farticle%2FS1530-891X%2826%2900828-1%2Fabstract].

Episode 75: AACE Journey for Patients With Obesity - Patient Perspective

Join endocrinologist Elizabeth Bauer, MD, FACP, FACE, DABOM, as she speaks with Michelle about her experience living with obesity, including the challenges, stigma, and turning points that shaped her path. Together, they explore the AACE Journey for Patients With Obesity, as Michelle shares which parts she found most helpful for understanding obesity as a chronic disease and navigating next steps. Don’t miss this inspiring discussion, brought to you with the support of Boehringer-Ingelheim, Lilly, Novo Nordisk, and Amgen.

Episode 74: 2026 AACE Algorithm for Management of Adults with Type 2 Diabetes: Key Updates and Clinical Insights

Join endocrine expert Vin Tangpricha, MD, PhD, as he moderates a discussion with members of the task force behind the updated 2026 AACE Consensus Statement: Algorithm for the Management of Adults with Type 2 Diabetes. AACE Past President and Chair Susan L. Samson, MD, PhD, FRCPC, FACE, is joined by Vice Chair Priyathama Vellanki, MD, along with Lawrence Blonde, MD, FACP, MACE, and Irl B. Hirsch, MD, MACP, to discuss key changes. Together, they explore how the new algorithm supports more individualized, complications-focused care and provides practical guidance clinicians can apply in everyday practice.

Episode 73: Understanding Hypophosphatemia: Recognition, Diagnosis, and Treatment

Join Dr. Steven Petak, Past President of AACE and ISCD and former Chief of Endocrinology at Houston Methodist Hospital, as he leads an in-depth conversation on Hypophosphatemia with Dr. Laila Tabatabai, Associate Professor of Clinical Medicine at Weill Cornell and metabolic bone specialist at Houston Methodist, and Dr. Basma Abdulhadi, Assistant Professor of Medicine at the University of Alabama at Birmingham and head of bone densitometry. Together, they discuss how to distinguish Hypophosphatemia from osteoporosis and osteomalacia, recognize key symptoms across ages, and apply a focused diagnostic workup. The discussion also highlights FGF23-mediated disorders, XLH, and current treatment approaches including burosumab, reinforcing a key reminder for clinicians to check phosphate levels to help prevent missed diagnoses. This episode is made possible through a sponsorship from Kyowa Kirin. Kyowa Kirin was not involved in the content of the podcast.